Evolus Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:EVL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24Sell€44,196Sandra BeaverIndividual3,276€13.49
30 Aug 24Sell€80,692Tomoko Yamagishi-DresslerIndividual5,631€14.33
04 Jun 24Sell€1,640,126David MoatazediIndividual140,214€11.70
03 Jun 24Sell€89,291Vikram MalikIndividual7,500€11.91
14 May 24Sell€121,105David GillIndividual10,361€11.76
13 May 24Sell€335,404Vikram MalikIndividual28,000€11.98
10 May 24Sell€28,611Sandra BeaverIndividual2,423€11.81
10 May 24Sell€40,632Rui AvelarIndividual3,441€11.81
10 May 24Sell€189,532David MoatazediIndividual16,051€11.81
27 Mar 24Sell€79,879David MoatazediIndividual6,236€12.81
19 Mar 24Sell€1,238,112David MoatazediIndividual96,566€12.82
19 Mar 24Sell€72,723Sandra BeaverIndividual5,672€12.82
19 Mar 24Sell€353,909Rui AvelarIndividual27,603€12.82
22 Feb 24Sell€93,193David MoatazediIndividual7,706€12.09

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EVL?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,197,5351.89%
Private Companies2,136,4493.37%
Public Companies3,136,8694.95%
General Public4,538,9357.17%
VC/PE Firms5,145,8468.13%
Institutions47,165,85974.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 72.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.13%
Perceptive Advisors LLC
5,145,846€73.1m-3.93%2.05%
7.89%
Tang Capital Management, LLC
4,997,399€71.0m3.09%4.55%
6.89%
BlackRock, Inc.
4,364,896€62.0m3.19%no data
5.01%
The Vanguard Group, Inc.
3,171,404€45.1m-0.75%no data
4.95%
Daewoong Pharmaceutical Co., Ltd
3,136,869€44.6m0%no data
4.94%
Nantahala Capital Management, LLC
3,130,149€44.5m10.8%3.02%
4.25%
Caligan Partners, LP
2,692,388€38.3m22.7%8.7%
3.37%
Medytox Korea Co. Ltd
2,136,449€30.4m-36.8%no data
2.25%
State Street Global Advisors, Inc.
1,422,369€20.2m11.3%no data
2.16%
Millennium Management LLC
1,368,423€19.4m32.9%0.02%
2.03%
Boothbay Fund Management, LLC
1,287,767€18.3m30.9%0.59%
2%
Stonepine Capital Management LLC
1,264,651€18.0m-7.68%7.47%
1.92%
Geode Capital Management, LLC
1,214,590€17.3m0.33%no data
1.91%
UBS Asset Management AG
1,208,457€17.2m60.4%no data
1.74%
Soros Fund Management LLC
1,100,000€15.6m29.4%0.36%
1.64%
Schroder Investment Management North America Inc.
1,040,440€14.8m2.51%0.05%
1.5%
Rice Hall James & Associates, LLC
948,281€13.5m4.79%0.73%
1.41%
Great Point Partners, LLC
895,524€12.7m-23.5%7.14%
1.34%
D. E. Shaw & Co., L.P.
848,176€12.1m-12.6%0.01%
1.21%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
767,212€10.9m-14.3%no data
1.19%
Qube Research & Technologies Ltd
754,079€10.7m33%0.02%
1.17%
Morgan Stanley, Investment Banking and Brokerage Investments
743,845€10.6m-24.1%no data
1.17%
Tri Locum Partners LP
742,574€10.6m0%2.25%
1.11%
Gilder Gagnon Howe & Co. LLC
702,239€10.0m287%0.1%
1.1%
Soleus Capital Management, L.P.
697,158€9.9m-32.8%0.7%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 01:28
End of Day Share Price 2025/02/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Evolus, Inc. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Balaji PrasadBarclays
Balaji PrasadBarclays
Navann Ty DietschiBNP Paribas Exane